P_%D9%85%D8%A7%D8%AF%D9%87%E2%80%8C%D8%B3%DB%8CSubst%C3%A0ncia_PSubstance_PSubstanz_PSubstance_PSustancia_P%D9%85%D8%A7%D8%AF%D9%87_PSubstanssi_PSubstance_PSubstaint_PSubstancia_PSostanza_PP%E7%89%A9%E8%B3%AASubstantie_PSubstancja_PSubst%C3%A2ncia_PSubstan%C8%9Ba_P%D0%92%D0%B5%D1%89%D0%B5%D1%81%D1%82%D0%B2%D0%BE_%D0%A0Supstanca_PSupstanca_PSubstans_PQ411041
about
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 3)Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2)This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 1Role of Copper-Albumin Complex in Treatment of Knee Osteoarthritis in HumanRole of Substance P in Post-Traumatic Stress DisorderEvaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQMeasurement of Substance P in Saliva of Low Back Pain PatientsThe Effect of Beta-blockers in Substance P Levels and the Swallowing Function
P4844
P688
The intellectual structure and substance of the knowledge utilization field: a longitudinal author co-citation analysis, 1945 to 2004.STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES: INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE IIIA qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co‑morbid substance use disordersSubstance P induces tumor necrosis factor-alpha release from human skin via mitogen-activated protein kinaseEffects of silica exposure on substance p immunoreactivity and preprotachykinin mRNA expression in trigeminal sensory neurons in Fischer 344 ratsToluene diisocyanate enhances substance P in sensory neurons innervating the nasal mucosaA review of the gastrointestinal effects from exposure to substances contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)Pulmonary exposure of rats to ultrafine titanium dioxide enhances cardiac protein phosphorylation and substance P synthesis in nodose gangliaExposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injuryDiacetyl increases sensory innervation and substance P production in rat tracheaAerosolized neutral endopeptidase reverses ozone-induced airway hyperreactivity to substance PHOCl causes airway substance P hyperresponsiveness and neutral endopeptidase hypoactivityInterleukin-1ß-induced airway hyperresponsiveness enhances substance P in intrinsic neurons of ferret airwayNon-specialist health worker interventions for the care of mental, neurological and substance-abuse disorders in low- and middle-income countriesMotivational interviewing for substance abuseNeuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-αEffects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytesIsolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cellsHydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidaseEffect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonistsHuman substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clonesTachykinin (substance-P) gene expression in Leydig cells of the human and mouse testisNuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascadeReceptor induction regulates the synergistic effects of substance P with IL-1 and platelet-derived growth factor on the proliferation of bone marrow fibroblastsAltered nociception, analgesia and aggression in mice lacking the receptor for substance PInhibitory effects of calcitonin gene-related peptide on substance-P-induced superoxide production in human neutrophilsLocalisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis.An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.Neurokinin-1 receptor desensitization to consecutive microdialysis infusions of substance P in human skinImpact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic responseSimilarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivityDelineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptorAbsence of histamine-induced itch in the African naked mole-rat and "rescue" by Substance PAn examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment programSubstance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitisIncreased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibitionModulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cellsDupuytren's contracture is associated with sprouting of substance P positive nerve fibres and infiltration by mast cellsMicrotrabecular lattice of the cytoplasmic ground substance. Artifact or realityDevelopment of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist
P921
Q61936528-65C5D7BD-5317-4CBB-ACF0-4199C39C0699Q61936529-6DA6FBB2-D2B0-4289-AA52-7878346CE119Q61965831-E17E475F-74C1-444B-9E42-C871F724B023Q62035236-5896A3F0-4413-450A-BB8A-DAAC85B0073DQ62035521-E455C7CF-172A-444A-8A62-27CFC4EC5C2AQ62106444-FD34CF28-4279-45DD-BBBE-0F6A5973B945Q62110156-9D582641-7F7A-42F5-806E-5A6911AE5B51Q63063404-E70C9C6B-A8B0-463B-BFD3-572C924D5AC4Q63811436-66F49DA6-8151-4617-9CAA-C1842349B7E4
P4844
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
composito chimic
@ia
name
P物質
@ja
Sostanza P
@it
Substaint P
@ga
Substance P
@cs
Substance P
@fr
Substancia P
@gl
Substancja P
@pl
Substans P
@sv
Substanssi P
@fi
Substantie P
@nl
type
label
P物質
@ja
Sostanza P
@it
Substaint P
@ga
Substance P
@cs
Substance P
@fr
Substancia P
@gl
Substancja P
@pl
Substans P
@sv
Substanssi P
@fi
Substantie P
@nl
altLabel
33507-63-0
@fr
C63H98N18O13S
@fr
C63H98N18O13S
@it
C63H98N18O13S
@sr
RPKPQQFFGLM-NH2
@en
SP
@en
SP
@eo
SP
@nn
Substance P
@nl
Substanţa P
@ro
prefLabel
P物質
@ja
Sostanza P
@it
Substaint P
@ga
Substance P
@cs
Substance P
@fr
Substancia P
@gl
Substancja P
@pl
Substans P
@sv
Substanssi P
@fi
Substantie P
@nl
P129
P31
P361
P638
P486
P508
P592
P6366
P661
P662
P683
P1417
science/substance-P
P2017
CC(C)C[C@@H](C(=O)N[C@@H](CCSC ...... ]4CCCN4C(=O)[C@H](CCCN=C(N)N)N
P2067
1,346.728146